Hepatitis Testing/Diagnosis Market to reach up to USD 4.4 billion by 2031, at a CAGR of 5.5% during the forecast period

New York, The Global Hepatitis Testing/Diagnosis Market was valued at USD 2.6 billion in 2021 and it is anticipated to reach up to USD 4.4 billion by 2031, at a CAGR of 5.5% during the forecast period.

Global Hepatitis Testing/Diagnosis Market report from Global Insight Services is the single authoritative source of intelligence on Hepatitis Testing/Diagnosis Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Read more about Hepatitis Testing/Diagnosis Market here: https://www.globalinsightservices.com/reports/hepatitis-testing-diagnosis-market/

The goal of hepatitis diagnosis is to identify the genotype of the infection that is causing the condition. The optimal course of treatment for the patient can be chosen based on the hepatitis diagnosis. In order to distinguish between different hepatitis viruses, it is crucial to make a diagnosis of the illness. Inflammation in the liver is the primary cause of hepatitis. Different forms of the hepatitis virus, including Hepatitis A, B, and C, are recognized. Blood tests are used to identify the presence of hepatitis disease. Testing bodily proteins or genetic material that is a component of the virus can also be used to identify hepatitis.

Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10295/

Market Trends and Drivers
Despite substantial advancements in treatment options, immunization coverage, and public awareness, hepatitis remains a serious public health concern with a high prevalence rate worldwide. The most common hepatitis forms, B and C, are associated with greater fatality rates. According to estimates, 296 million and 58 million persons, respectively, had chronic HBV and HCV infections in 2019. Compared to industrialized countries, hepatitis is more common in poor nations. Similarly, the biotechnology and biopharmaceutical industries have a significant demand for immunoassay equipment and supplies.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10295/

Global Hepatitis Testing/Diagnosis Market Segmental Overview
The report analyses the global hepatitis testing/diagnosis market based on disease type, technology, end user, and region.

Global Hepatitis Testing/Diagnosis Market by Type

Based on the type, it is segmented into hepatitis B, hepatitis C, and other hepatitis. The hepatitis B segment dominated the hepatitis testing market in 2021. Hepatitis B is becoming more common, there are more hepatitis B diagnostic tests available, and more people are using nucleic acid tests to diagnose HBV, which is what is fueling the growth of this market segment.

Global Hepatitis Testing/Diagnosis Market by Technology

Based on the technology, it is segmented into enzyme-linked immunosorbent assay, rapid diagnostic tests, polymerase chain reaction, isothermal nucleic acid amplification technology, and other technologies. The ELISA segment to witness the highest market share during the projection period. The substantial proportion of this market is primarily due to the widespread use of this test to identify hepatitis in clinical settings.

Global Hepatitis Testing/Diagnosis Market by End User

Based on the end user, it is segmented into hospital & diagnostic laboratories, blood banks, and other end users. The hospital & diagnostic laboratories segment is anticipated to witness the fastest growth during the forecast period. The key factors such as high burden of hepatitis coupled with increasing blood transfusion and donations are boosting the growth of the segment in the market.

Geographical Analysis of the Global Hepatitis Testing/Diagnosis Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America was the largest regional market for hepatitis testing/diagnosis market in 2021. The rapid growth and significant share of this region can be linked to the US's expanded hepatitis testing research and clinical trials as well as the disease's rising prevalence.

Major Players in the Global Hepatitis Testing/Diagnosis Market
The key players studied in the market are F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), QIAGEN (Netherlands), bioMérieux SA (France), DiaSorin S.P.A. (Italy), Ortho Clinical Diagnostics (US), MedMira Inc. (Canada), and Fujirebio US, Inc. (Japan) among others.

Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10295/

With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.